Company Accounts and Tax Online 13569136 Board of Directors 1.9.24 31.8.25 31.8.25 No description of principal activity true 13569136 uk-bus:EntityHasNeverTraded 2024-09-01 2025-08-31 iso4217:GBP xbrli:pure 13569136 2023-09-01 2024-08-31 13569136 2025-08-31 13569136 2024-09-01 2025-08-31 13569136 2024-08-31 13569136 countries:EnglandWales 2024-09-01 2025-08-31 13569136 curr:PoundSterling 2024-09-01 2025-08-31 13569136 uk-bus:PrivateLimitedCompanyLtd 2024-09-01 2025-08-31 13569136 uk-bus:Micro-entities 2024-09-01 2025-08-31 13569136 uk-bus:AuditExempt-NoAccountantsReport 2024-09-01 2025-08-31 13569136 uk-bus:FullAccounts 2024-09-01 2025-08-31 13569136 uk-bus:RegisteredOffice 2024-09-01 2025-08-31 13569136 uk-bus:Director1 2024-09-01 2025-08-31 13569136 uk-bus:Director1 2024-09-01 13569136 uk-bus:Director1 2025-08-31 13569136 uk-bus:Director2 2024-09-01 2025-08-31 13569136 uk-bus:Director2 2024-09-01 13569136 uk-bus:Director2 2025-08-31 13569136 uk-bus:Director3 2024-09-01 2025-08-31 13569136 uk-bus:Director3 2024-09-01 13569136 uk-bus:Director3 2025-08-31 13569136 core:AfterOneYear 2025-08-31 13569136 core:AfterOneYear 2024-08-31 13569136 core:WithinOneYear 2025-08-31 13569136 core:WithinOneYear 2024-08-31 13569136 core:WithinOneYear 2024-09-01 2025-08-31 13569136 core:AfterOneYear 2025-08-31 13569136 core:AfterOneYear 2024-08-31 13569136 core:AfterOneYear 2024-09-01 2025-08-31 13569136 core:ShareCapital 2025-08-31 13569136 core:ShareCapital 2024-08-31 13569136 core:RevaluationReserve 2025-08-31 13569136 core:RevaluationReserve 2024-08-31 13569136 core:RetainedEarningsAccumulatedLosses 2025-08-31 13569136 core:RetainedEarningsAccumulatedLosses 2024-08-31 13569136 1 2024-09-01 2025-08-31

# THERAPEUTIC TECHNOLOGY AND INNOVATION GROUP LIMITED

## Company Registration Number:
13569136 (England and Wales)

## Unaudited micro entity accounts for the year ended 31 August 2025

## (Dormant)

## Period of accounts

## Start date: 01 September 2024

## End date: 31 August 2025

# THERAPEUTIC TECHNOLOGY AND INNOVATION GROUP LIMITED

## Contents of the Financial Statements

for the Period Ended 31 August 2025

Company Information - 3 |
Report of the Directors - 4 |
Balance sheet - 5 |
Footnotes to the Balance Sheet - 7 |

# THERAPEUTIC TECHNOLOGY AND INNOVATION GROUP LIMITED

## Company Information

for the Period Ended 31 August 2025

Director: |  | Cyrus Mehdi Zadeh
|  | Mehdi Saberi
|  | Saam Mehdizadeh
Registered office: |  | 239 Petersham Road Richmond England TW10 7DA
Company Registration Number: |  | 13569136 (England and Wales)

# THERAPEUTIC TECHNOLOGY AND INNOVATION GROUP LIMITED

## Directors' Report Period Ended 31 August 2025

The directors present their report with the financial statements of the company for the period ended 31 August 2025

Directors

The directors shown below have held office during the whole of the period from 01 September 2024 to 31 August 2025
Cyrus Mehdi Zadeh
Mehdi Saberi
Saam Mehdizadeh

The company was dormant and did not trade in the period.

This report was approved by the board of directors on 15 October 2025
And Signed On Behalf Of The Board By:

Name: Cyrus Mehdi Zadeh
Status: Director

Name: Mehdi Saberi
Status: Director

Name: Saam Mehdizadeh
Status: Director

# THERAPEUTIC TECHNOLOGY AND INNOVATION GROUP LIMITED

## Balance sheet

As at 31 August 2025

| 2025 £ | 2024 £
--- | --- | ---
Called up share capital not paid: | 100 | 100
Fixed Assets: | 0 | 0
Current assets: | 0 | 0
Prepayments and accrued income: | 0 | 0
Creditors: amounts falling due within one year: | ( 0 ) | ( 0 )
Net current assets (liabilities): | 0 | 0
Total assets less current liabilities: | 100 | 100
Creditors: amounts falling due after more than one year: | ( 0 ) | ( 0 )
Provision for liabilities: | ( 0 ) | ( 0 )
Accruals and deferred income: | ( 0 ) | ( 0 )
Total net assets (liabilities): | 100 | 100
Capital and reserves: | 100 | 100

# THERAPEUTIC TECHNOLOGY AND INNOVATION GROUP LIMITED

## Balance sheet continued

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions of the small companies regime applicable to micro-entities.

For the year ending 31 August 2025 the company was entitled to exemption under section 480 of the Companies Act 2006 relating to dormant companies.

This report was approved by the board of directors on 15 October 2025
And Signed On Behalf Of The Board By:

Name: Cyrus Mehdi Zadeh
Status: Director

Name: Mehdi Saberi
Status: Director

Name: Saam Mehdizadeh
Status: Director

The notes form part of these financial statements

# THERAPEUTIC TECHNOLOGY AND INNOVATION GROUP LIMITED

## Footnotes to the Financial Statements

for the Period Ended 31 August 2025

- ## 1. Employee Information

  Average number of employees: 0

# THERAPEUTIC TECHNOLOGY AND INNOVATION GROUP LIMITED

## Footnotes to the Financial Statements

for the Period Ended 31 August 2025

- ## 2. Off balance sheet disclosure

  No